Selected research
Industry Growth & Trends
Global Female Sexual Dysfunction Treatment Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Female Sexual Dysfunction Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Female Sexual Dysfunction Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Female Sexual Dysfunction Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Female Sexual Dysfunction Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Female Sexual Dysfunction Treatment market include Novo Nordisk AS, Sprout Pharmaceuticals Inc., Emotional Brain BV, Duchesnay Inc. and AMAG Pharmaceuticals Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Female Sexual Dysfunction Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Female Sexual Dysfunction Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Female Sexual Dysfunction Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Female Sexual Dysfunction Treatment.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Female Sexual Dysfunction Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Female Sexual Dysfunction Treatment Market by Company
Novo Nordisk AS
Sprout Pharmaceuticals Inc.
Emotional Brain BV
Duchesnay Inc.
AMAG Pharmaceuticals Inc.
Female Sexual Dysfunction Treatment Segment by Type
Non-hormonal Therapy
Hormonal Therapy
Female Sexual Dysfunction Treatment Segment by Application
Pelvic Floor Dysfunction
Post-orgasmic Diseases
Orgasm Disorders
Sexual Arousal Disorders
Sexual Pain Disorders
Sexual Desire Disorders
Other
Female Sexual Dysfunction Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Female Sexual Dysfunction Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Female Sexual Dysfunction Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Female Sexual Dysfunction Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Female Sexual Dysfunction Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Non-hormonal Therapy
- Hormonal Therapy
Applications
- Pelvic Floor Dysfunction
- Post-orgasmic Diseases
- Orgasm Disorders
- Sexual Arousal Disorders
- Sexual Pain Disorders
- Sexual Desire Disorders
- Other
Companies covered
- Novo Nordisk AS
- Sprout Pharmaceuticals Inc.
- Emotional Brain BV
- Duchesnay Inc.
- AMAG Pharmaceuticals Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Female Sexual Dysfunction Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Female Sexual Dysfunction Treatment Market Size by Region (2021-2032)
- 1.4.1 Global Female Sexual Dysfunction Treatment Market Size by Region (2021-2026)
- 1.4.2 Global Female Sexual Dysfunction Treatment Market Size by Region (2027-2032)
- 1.5 Key Regions Female Sexual Dysfunction Treatment Market Size (2021-2032)
- 1.5.1 North America Female Sexual Dysfunction Treatment Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Female Sexual Dysfunction Treatment Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Female Sexual Dysfunction Treatment Market Size Growth Rate (2021-2032)
- 1.5.4 South America Female Sexual Dysfunction Treatment Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Female Sexual Dysfunction Treatment Market Size Growth Rate (2021-2032)
2 Female Sexual Dysfunction Treatment Market by Type
- 2.1 Type Introduction
- 2.1.1 Non-hormonal Therapy
- 2.1.2 Hormonal Therapy
- 2.2 Global Female Sexual Dysfunction Treatment Market Size by Type
- 2.2.1 Global Female Sexual Dysfunction Treatment Market Size Overview by Type (2021-2032)
- 2.2.2 Global Female Sexual Dysfunction Treatment Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Female Sexual Dysfunction Treatment Market Size Forecasted by Type (2027-2032)
- 2.3 Global Female Sexual Dysfunction Treatment Market Size by Regions
- 2.3.1 North America Female Sexual Dysfunction Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Female Sexual Dysfunction Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Female Sexual Dysfunction Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Female Sexual Dysfunction Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Female Sexual Dysfunction Treatment Market Size Breakdown by Type (2021-2026)
3 Female Sexual Dysfunction Treatment Market by Application
- 3.1 Type Introduction
- 3.1.1 Pelvic Floor Dysfunction
- 3.1.2 Post-orgasmic Diseases
- 3.1.3 Orgasm Disorders
- 3.1.4 Sexual Arousal Disorders
- 3.1.5 Sexual Pain Disorders
- 3.1.6 Sexual Desire Disorders
- 3.1.7 Other
- 3.2 Global Female Sexual Dysfunction Treatment Market Size by Application
- 3.2.1 Global Female Sexual Dysfunction Treatment Market Size Overview by Application (2021-2032)
- 3.2.2 Global Female Sexual Dysfunction Treatment Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Female Sexual Dysfunction Treatment Market Size Forecasted by Application (2027-2032)
- 3.3 Global Female Sexual Dysfunction Treatment Market Size by Regions
- 3.3.1 North America Female Sexual Dysfunction Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Female Sexual Dysfunction Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Female Sexual Dysfunction Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Female Sexual Dysfunction Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Female Sexual Dysfunction Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Female Sexual Dysfunction Treatment Industry Trends
- 4.2 Female Sexual Dysfunction Treatment Industry Drivers
- 4.3 Female Sexual Dysfunction Treatment Industry Opportunities and Challenges
- 4.4 Female Sexual Dysfunction Treatment Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Female Sexual Dysfunction Treatment Revenue (2021-2026)
- 5.2 Global Female Sexual Dysfunction Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Female Sexual Dysfunction Treatment Key Company Headquarters & Area Served
- 5.4 Global Female Sexual Dysfunction Treatment Company, Product Type & Application
- 5.5 Global Female Sexual Dysfunction Treatment Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Female Sexual Dysfunction Treatment Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Female Sexual Dysfunction Treatment Players Market Share by Revenue in 2025
- 5.6.3 2025 Female Sexual Dysfunction Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Novo Nordisk AS
- 6.1.1 Novo Nordisk AS Company Information
- 6.1.2 Novo Nordisk AS Business Overview
- 6.1.3 Novo Nordisk AS Female Sexual Dysfunction Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Novo Nordisk AS Female Sexual Dysfunction Treatment Product Portfolio
- 6.1.5 Novo Nordisk AS Recent Developments
- 6.2 Sprout Pharmaceuticals Inc.
- 6.2.1 Sprout Pharmaceuticals Inc. Company Information
- 6.2.2 Sprout Pharmaceuticals Inc. Business Overview
- 6.2.3 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Portfolio
- 6.2.5 Sprout Pharmaceuticals Inc. Recent Developments
- 6.3 Emotional Brain BV
- 6.3.1 Emotional Brain BV Company Information
- 6.3.2 Emotional Brain BV Business Overview
- 6.3.3 Emotional Brain BV Female Sexual Dysfunction Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Emotional Brain BV Female Sexual Dysfunction Treatment Product Portfolio
- 6.3.5 Emotional Brain BV Recent Developments
- 6.4 Duchesnay Inc.
- 6.4.1 Duchesnay Inc. Company Information
- 6.4.2 Duchesnay Inc. Business Overview
- 6.4.3 Duchesnay Inc. Female Sexual Dysfunction Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Duchesnay Inc. Female Sexual Dysfunction Treatment Product Portfolio
- 6.4.5 Duchesnay Inc. Recent Developments
- 6.5 AMAG Pharmaceuticals Inc.
- 6.5.1 AMAG Pharmaceuticals Inc. Company Information
- 6.5.2 AMAG Pharmaceuticals Inc. Business Overview
- 6.5.3 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Portfolio
- 6.5.5 AMAG Pharmaceuticals Inc. Recent Developments
7 North America
- 7.1 North America Female Sexual Dysfunction Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Female Sexual Dysfunction Treatment Market Size by Country (2021-2026)
- 7.3 North America Female Sexual Dysfunction Treatment Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Female Sexual Dysfunction Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Female Sexual Dysfunction Treatment Market Size by Country (2021-2026)
- 8.3 Europe Female Sexual Dysfunction Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Female Sexual Dysfunction Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Female Sexual Dysfunction Treatment Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Female Sexual Dysfunction Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Female Sexual Dysfunction Treatment Market Size by Country (2021-2026)
- 10.3 South America Female Sexual Dysfunction Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Female Sexual Dysfunction Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Female Sexual Dysfunction Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst